- 期刊
- OpenAccess
Progress in the Pharmacotherapy of Menstrual Migraine
並列摘要
Menstrual migraine is a common neurological condition reported to affect up to 60% of women with migraine. Most women manage migraine adequately with symptomatic treatment alone. However, in women with menstrual migraine, menstrual attacks are recognised to be more severe, last longer, and are less responsive to treatment compared with attacks at other times of the menstrual cycle. In these situations, prophylactic treatment may be necessary. Short-term perimenstrual and continuous prophylactic treatments have shown efficacy in clinical trials but none are licensed for menstrual migraine. This article reviews the evidence for acute and prophylactic drugs in the management of this condition and considers future therapeutic options.
延伸閱讀
- 張學岭、李明濱（1997）。Psychosomatic Aspects of Premenstrual Syndrome。台灣醫學，1(2)，230-236。https://doi.org/10.6320/FJM.1997.1(2).14
- 劉彥麟、吳逸群（2007）。TCM Treatment of Migraine: A Case Study。台灣中醫臨床醫學雜誌，13(4)，301-307。https://doi.org/10.6968/TJCCM.200712.0301
- 邱浩彰（1998）。Neurology: Recent Advance in Migraine Studies。台灣醫學，2(5)，582-585。https://doi.org/10.6320/FJM.1998.2(5).14
- Gooriah, R., Nimeri, R., & Ahmed, F. (2015). Evidence-Based Treatments for Adults with Migraine. Pain Research and Treatment, 2015(), 107-119. https://doi.org/10.1155/2015/629382
- Shahien, R., & Beiruti, K. (2012). Preventive Agents for Migraine: Focus on the Antiepileptic Drugs. Journal of Central Nervous System Disease, (), 37-49. https://doi.org/10.4137/JCNSD.S9049